Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by palinc2000on Jun 24, 2021 9:25am
118 Views
Post# 33440625

RE:RE:RE:RE:RE:RE:RE:RE:RE:Question

RE:RE:RE:RE:RE:RE:RE:RE:RE:Question

I agree that naming and shaming is not useful but I did not start that and I will retaliate whenever HE does it again.
My one and only purpose in being invested in THTX is to make money... and i call shots as I see them from my business background .
So when Katana was acquired I was bothered by 3 things
1- Katana had been looking for a partner and or a buyout for more than a year and in spite of the very low acquisition price there were no takers from biotechs and pharmas involved in oncology
2-Apart from a few low milestone payments related to the start of clinical trial and proof of concept the selling shareholders of Katana will not be receiving any royalties from any revenue related to the platform.Their confidence level in success did not seem very high
3- I also had concerns about diversification in oncology which was never ever hinted at before by management ....The fact that Christian has knowledge in oncology was not in my mind a valid reason to enter the field especially when considering 1 and 2 above.
So I called it a Lottery Ticket .... meaning high risk and low probability .... 

Do I want the platform to be successful ? OF COURSE I DO
It has been almost 2 1/2 years since the acquisition and I that all pre clinical results  since then point to the same direction...so I am hoping for the best 

scarlet1967 wrote: Apart from personal naming and shaming  from both sides I agree with palinc, we are all here to understand our investment based on openions often we make the right analysis and sometimes not.
These conversations are not about I said so you said so I am right your wrong etc.
To claim that one has been always right or one knows best is not correct or helpful.
To me a collective knowledge of all posters and their understandings are much more helpful than egotistical posts. We all have been wrong many times to claim anything but that is silly. Writing posts about how knowledgeable one is based on their whatever background is waste of time, your skills will be reflected in your analysis no point to justify it by self claiming that you have whatever background in various areas.

 

<< Previous
Bullboard Posts
Next >>